Decision and Details
Board of DirectorsLoan of funds to Kaihan Medical Co., Ltd. (the loan in question)
The purpose is to create synergies with the healthcare business in areas including the future implementation of and operational support for systems for medical institutions, thereby accelerating consideration of collaboration and strengthening the relationship. The company will provide short-term financial support to help establish the business foundation of clinics supported by the counterparty, with the aim of building a relationship for a specific business alliance in the future.
The impact on results for the fiscal year ending September 2026 is currently under review. If any matters requiring disclosure arise, the company will promptly disclose them.
| Item | Details |
|---|---|
| Matter Covered | Loan of funds to Kaihan Medical Co., Ltd. (the loan in question) |
| Decision-Making Body | Board of Directors |
| Decision Date | 30 June 2026 |
| Implementation Date | 30 June 2026 (appears to be the loan date, but it is not stated whether the loan has been made or is scheduled to be made) |
| Period Covered | 30 June 2026 to 30 September 2026 |
| Amount | Loan amount: ¥125 million; interest rate: 15.0% per annum |
| Impact on Business Performance | The impact on results for the fiscal year ending September 2026 is currently under review. If any matters requiring disclosure arise, the company will promptly disclose them. |
| Reason | The purpose is to create synergies with the healthcare business in areas including the future implementation of and operational support for systems for medical institutions, thereby accelerating consideration of collaboration and strengthening the relationship. The company will provide short-term financial support to help establish the business foundation of clinics supported by the counterparty, with the aim of building a relationship for a specific business alliance in the future. |
| Future plans | Bullet repayment at maturity on 30 September 2026. If any matters requiring disclosure arise, the company will promptly disclose them. |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The purpose is to accelerate consideration of collaboration and strengthen the relationship with a view to future collaboration in areas including the implementation and operational support of systems for medical institutions. The company will provide short-term financial support to help establish the business foundation of clinics supported by the counterparty, with the aim of building a relationship for a specific business alliance in the future.